Douglas Pharmaceuticals diversifies in in growth quests
Article – BusinessDesk Feb. 13 (BusinessDesk) – Douglas Pharmaceuticals, New Zealands largest developer and manufacturer of generic pharmaceuticals, is targeting annual revenues of $244 million by 2020 from $145 million today as it diversifies and seeks higher risk, …
Douglas Pharmaceuticals diversifies in in growth quests Read More »